Voloridge Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,607
| Closed | -$1.16M | – | 1552 |
|
|
2023
Q3 | $1.16M | Sell |
26,607
-379,428
| -93% | -$16.5M | 0.01% | 1067 |
|
|
2023
Q2 | $14.7M | Sell |
406,035
-272,623
| -40% | -$9.85M | 0.07% | 369 |
|
|
2023
Q1 | $25.2M | Buy |
678,658
+524,038
| +339% | +$19.5M | 0.13% | 240 |
|
|
2022
Q4 | $7.01M | Buy |
154,620
+130,363
| +537% | +$5.91M | 0.04% | 539 |
|
|
2022
Q3 | $1.69M | Sell |
24,257
-375,923
| -94% | -$26.3M | 0.01% | 1031 |
|
|
2022
Q2 | $26.9M | Buy |
400,180
+339,781
| +563% | +$22.8M | 0.14% | 217 |
|
|
2022
Q1 | $4.97M | Buy |
+60,399
| New | +$4.97M | 0.03% | 641 |
|
|
2021
Q3 | – | Sell |
-4,622
| Closed | -$747K | – | 1930 |
|
|
2021
Q2 | $747K | Sell |
4,622
-19,496
| -81% | -$3.15M | 0.01% | 1341 |
|
|
2021
Q1 | $4.13M | Buy |
24,118
+9,948
| +70% | +$1.7M | 0.03% | 590 |
|
|
2020
Q4 | $3.11M | Buy |
14,170
+2,123
| +18% | +$466K | 0.03% | 592 |
|
|
2020
Q3 | $2M | Buy |
+12,047
| New | +$2M | 0.02% | 725 |
|
|
2019
Q3 | – | Sell |
-29,071
| Closed | -$2.99M | – | 1251 |
|
|
2019
Q2 | $2.99M | Sell |
29,071
-6,906
| -19% | -$711K | 0.08% | 254 |
|
|
2019
Q1 | $2.64M | Buy |
+35,977
| New | +$2.64M | 0.08% | 245 |
|